Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males ; volume:42 ; number:4 ; day:14 ; month:3 ; year:2022 ; pages:375 ; date:4.2022
Clinical drug investigation ; 42, Heft 4 (14.3.2022), 375, 4.2022
- Urheber
-
Burkard, Ute
Desch, Michael
Shatillo, Yury
Wunderlich, Glen
Mack, Salome Rebecca
Schlecker, Christina
Teitelbaum, Aaron M.
Liu, Pingrong
Chan, Tom S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-022-01134-w
- URN
-
urn:nbn:de:101:1-2022062508541588520662
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Burkard, Ute
- Desch, Michael
- Shatillo, Yury
- Wunderlich, Glen
- Mack, Salome Rebecca
- Schlecker, Christina
- Teitelbaum, Aaron M.
- Liu, Pingrong
- Chan, Tom S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
![The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males](/assets/placeholder/searchResultMediaUnknown.png)
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males
Low-dose oral methotrexate-induced crystalluria
Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
Low dose oral and transdermal therapy of hypertension
Palliative low dose fortnightly methotrexate in oral cancer
ALLeS SHeIße WAND BiLD UND DOSeN aUCH
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats
Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial
Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males
Low-dose oral methotrexate-induced crystalluria
Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
Low dose oral and transdermal therapy of hypertension
Palliative low dose fortnightly methotrexate in oral cancer
ALLeS SHeIße WAND BiLD UND DOSeN aUCH
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats
Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial
Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males
Low-dose oral methotrexate-induced crystalluria
Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans
Low dose oral and transdermal therapy of hypertension
Palliative low dose fortnightly methotrexate in oral cancer
ALLeS SHeIße WAND BiLD UND DOSeN aUCH
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats
Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial
Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers